Laparoscopic retroperitoneal lymph node dissection (RPLND) has been shown to be safe and effective in appropriately selected pediatric and adolescent patients with paratesticular rhabdomyosarcoma (RMS) and testicular germ-cell tumors (T-GCT). While the use of robot-assisted laparoscopy has expanded rapidly in many areas, there are very limited reports of its use with RPLND. We present two cases of adolescents who were treated using robot-assisted laparoscopic RPLND (R-RPLND)—one with paratesticular RMS (PT-RMS) and one with testicular GCT (T-GCT)—with good outcomes and low morbidity.
Get full access to this article
View all access options for this article.
References
1.
WienerES, AndersonJR, OjimbaJIet al.Controversies in the management of paratesticular rhabdomyosarcoma: Is staging retroperitoneal lymph node dissection necessary for adolescents with resected paratesticular rhabdomyosarcoma?Semin Pediatr Surg, 2001; 10:146–152.
2.
AhmedHU, AryaM, MuneerAet al.Testicular and paratesticular tumours in the prepubertal population. Lancet Oncol, 2010; 11:476–483.
3.
RukstalisDB, ChodakGW. Laparoscopic retroperitoneal lymph node dissection in a patient with stage 1 testicular carcinoma. J Urol, 1992; 148:1907–1910.
International Germ Cell Consensus Classification. A prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group. J Clin Oncol, 1997; 15:594–603.
CristWM, AndersonJR, MezaJLet al.Intergroup rhabdomyosarcoma study-IV: Results for patients with nonmetastatic disease. J Clin Oncol, 2001; 19:3091–3102.
12.
AlbqamiN, JanetschekG. Laparoscopic retroperitoneal lymph-node dissection in the management of clinical stage I and II testicular cancer. J Endourol, 2005; 19:683–692.
13.
SubramanianVS, NguyenCT, StephensonAJ, KleinEA. Complications of open primary and post-chemotherapy retroperitoneal lymph node dissection for testicular cancer. Urol Oncol, 2010; 28:504–509.
14.
KenneyPA, TuerkIA. Complications of laparoscopic retroperitoneal lymph node dissection in testicular cancer. World J Urol, 2008; 26:561–569.
15.
DoumercN, YuenC, SavdieRet al.Should experienced open prostatic surgeons convert to robotic surgery? The real learning curve for one surgeon over 3 years. BJU Int, 2010; 106:378–384.
16.
LernerMA, AyalewM, PeineWJet al.Does training on a virtual reality robotic simulator improve performance on the da Vinci surgical system?J Endourol, 2010; 24:467–472.
17.
LeroyTJ, ThielDD, DucheneDAet al.Safety and peri-operative outcomes during learning curve of robot-assisted laparoscopic prostatectomy: A multi-institutional study of fellowship-trained robotic surgeons versus experienced open radical prostatectomy surgeons incorporating robot-assisted laparoscopic prostatectomy. J Endourol, 2010; 24:1665–1669.
18.
AhleringTE, SkareckyD, LeeD, ClaymanRV. Successful transfer of open surgical skills to a laparoscopic environment using a robotic interface: Initial experience with laparoscopic radical prostatectomy. J Urol, 2003; 170:1738–1741.
19.
CarverBS, CroninAM, EggenerSet al.The total number of retroperitoneal lymph nodes resected impacts clinical outcome after chemotherapy for metastatic testicular cancer. Urology, 2010; 75:1431–1425.
20.
MorcosB, BakerB, Al MasriMet al.Lymph node yield in rectal cancer surgery: Effect of preoperative chemoradiotherapy. Eur J Surg Oncol, 2010; 36:345–349.
21.
MirSA, CadedduJA, SleeperJP, LotanY. Cost comparison of robotic, laparoscopic, and open partial nephrectomy. J Endourol, 2011; 25:447–453.
